Aandelen in “Testlaboratoria”

Aandeel Datum Koers Evolutie
vlag Oxford BioDynamics Plc 16/02 0,290 GBX
-3,33% 		-3,33%

Nieuws over “Testlaboratoria”

12/02 · 10x Genomics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Outlook for 2026 · Persbericht

12/02 · 10x Genomics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Outlook for 2026 · Persbericht

4/02 · PharosAI and 10x Genomics Partner to Transform Cancer Research with AI and Spatial Biology · Persbericht

4/02 · WENDEL: Agreement to sell Stahl, the global leader in specialty coatings for flexible materials, to Henkel · Persbericht

22/01 · 10x Genomics to Report Fourth Quarter and Full Year 2025 Financial Results on February 12, 2026 · Persbericht

22/01 · Pilot Study Finds 30-Day Molecular Improvement in Prostate Health Following Intraprostatic Ozone Therapy, Tracked by the EpiSwitch® PSE Blood Test · Persbericht

19/01 · WENDEL: Statement · Persbericht

19/01 · WENDEL: Wendel Investment Managers affiliates successfully raised over €11 billion in European Private Equity & US Private Credit Markets · Persbericht

12/01 · 10x Genomics Launches Study to Advance Research in Blood-Based Diagnostics for Autoimmune Disease · Persbericht

12/01 · 10x Genomics to Advance Research in Diagnostic Applications of Tumor Single Cell and Spatial Profiling · Persbericht

12/01 · Cancer Research Institute Launches Transformative AI-Driven Immuno-Oncology Initiative Powered by 10x Genomics Technology · Persbericht

11/01 · 10x Genomics Announces Preliminary Select Fourth Quarter and Full Year 2025 Results · Persbericht

29/12 · 10x Genomics to Present at the 44th Annual J.P. Morgan Healthcare Conference · Persbericht

12/12 · WENDEL: Wendel Investor Day · Persbericht

25/11 · WENDEL: Signing of the acquisition agreement of Committed Advisors · Persbericht

18/11 · New ASTRA Consortium Unites Asia-Pacific Scientists to Build Pan-Cancer Spatial Atlas Powered by 10x Genomics' Xenium · Persbericht

Mijn selecties